METTL3 and neoplasm: As the key catalytic subunit mediating m6A modification, METTL3 has been reported to be expressed aberrantly in various tumors, including hematopoietic malignancies and solid tumors, and plays vital roles in tumor progression as an m6A regulator, either as a tumor suppressor or an oncogene [47].